Orrstown Financial Services Inc. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,322 shares of the medical equipment provider’s stock after selling 31 shares during the period. Orrstown Financial Services Inc.’s holdings in Intuitive Surgical were worth $655,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of ISRG. Brighton Jones LLC boosted its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new stake in Intuitive Surgical during the fourth quarter valued at $6,509,000. Triasima Portfolio Management inc. acquired a new stake in Intuitive Surgical during the fourth quarter valued at $266,000. Conning Inc. boosted its position in Intuitive Surgical by 7.4% during the fourth quarter. Conning Inc. now owns 3,629 shares of the medical equipment provider’s stock valued at $1,894,000 after purchasing an additional 249 shares during the last quarter. Finally, Vest Financial LLC boosted its position in Intuitive Surgical by 22.1% during the fourth quarter. Vest Financial LLC now owns 2,725 shares of the medical equipment provider’s stock valued at $1,422,000 after purchasing an additional 493 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
Insider Buying and Selling at Intuitive Surgical
In other news, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president now directly owns 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 25,443 shares of company stock valued at $12,692,195 in the last quarter. Corporate insiders own 0.70% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Stock Down 0.2%
Intuitive Surgical stock opened at $557.08 on Friday. The business has a 50 day moving average price of $521.99 and a two-hundred day moving average price of $539.24. The stock has a market cap of $199.67 billion, a price-to-earnings ratio of 86.91, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 12 month low of $413.52 and a 12 month high of $616.00.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the firm posted $1.50 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
- What is the Australian Securities Exchange (ASX)
- 3 Oversold Stocks Flashing Bullish Reversal Signals
- How to Invest in Insurance Companies: A GuideĀ
- With Novo Nordisk’s CEO Out, Wall Street Wants an American Leader
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.